Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: A case series

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 9, 2002, Pages 1020-1024

  Rodie, V A ^a,c   Thomson, A J ^b   Stewart, F M ^a   Quinn, A J ^b   Walker, I D ^a   Greer, I A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGIONAL ANESTHESIA; SIDE EFFECT; SKIN ALLERGY; THROMBOCYTOPENIA; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; ANTITHROMBIN III; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0036754654     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(02)01525-2     Document Type: Article

References (33)

1. Bonnar J. Haemostasis and coagulation disorders in pregnancy. Bloom A.L., Thomas D.P. Haemostasis and Thrombosis. 34:1987;570-584 Churchill, London.
2. Department of Health, Welsh Office, Scottish Home and Health Department and Department of Health and Social Services Northern Ireland Confidential Enquiries into Maternal Deaths in the United Kingdom 1994-1996. 1998;TSO, London.
3. Scottish Intercollegiate Guidelines Network (SIGN) Antithrombotic Therapy. 1999;SIGN, Edinburgh.
4. Ensom M.H.H., Stephenson M.D. Low molecular weight heparins in pregnancy. Pharmacotherapy. 19:1999;1013-1025.
5. Sanson B.J., Lensing A.W.A., Prins MHet al. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemost. 81:1999;668-672.
6. Hyers T.M., Hull R.D., Weg J.G. Antithrombotic therapy for venous thromboembolic disease. Chest. 108:1995;335s-351s.
7. Wheeler A.P., Jaquiss R.D.B., Newman J.H. Physician practices in the treatment of pulmonary embolism and deep vein thrombosis. Arch Intern Med. 148:1988;1321-1325.
8. Thomson A.J., Walker I.D., Greer I.A. Low molecular weight heparin for the immediate management of thromboembolic disease in pregnancy. Lancet. 352:1998;1904.
9. Warkentin T.E., Kelton J.G. Temporal aspects of heparin induced thrombocytopenia. N Engl J Med. 334(17):2001;1286-1292. April 26.
10. Ginsberg J.S., Greer I.A., Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 119:2001;1225-1315.
11. Thomson AJ, Greer IA. Thromboembolic disease in pregnancy and the puerperium: acute management. RCOG Guideline Number 28. London: RCOG Press, 2001.
12. Checketts M.R., Wildsmith J.A.W. Central nerve block and thromboprophylaxis - is there a problem? Br J Anaesth. 82:1999;164-167.
13. Gogarten W., Van Aken H., Wulf Het al. Ruckenmarksnahe regionalanassthesien und thromboembolieprophylaxe/anticoagulation. Anasthesiol Intensivmed. 12:1997;623-628.
14. Horlocker T.T., Wedel D.J. Spinal and epidural blockade and perioperative low molecular weight heparin: smooth sailing on the Titanic. Anesth Analg. 86:1998;1153-1156.
15. Thomson A.J., Greer I.A. Non-haemorrhagic obstetric shock. Thompson W., TambyRaja R.L. Emergencies in Obstetrics and Gynaecology. Baillière's Clin Obstet Gynaecol. 14:2000;19-41.
16. Dahlman T.C., Hellgren M.S.E., Blomback M. Thrombosis prophylaxis in pregnancy with use of subcutaneous heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol. 161:1989;420-425.
17. Toglia M.R., Weg J.G. Venous thromboembolism during pregnancy. N Engl J Med. 335:1996;108-114.
18. Kanis J.A. Heparin in the treatment of pulmonary thromboembolism. Thromb Diath Haemorrh. 32:1974;519-527.
19. Carson J.L., Kelley M.A., Duff Aet al. The clinical course of pulmonary embolism. N Engl J Med. 326:1992;1240-1245.
20. Barritt D.V., Jordan S.C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet. 1:1960;1309-1312.
21. Fennerty A., Campbell I.A., Routledge P.A. Anticoagulants in venous thromboembolism. BMJ. 297:1988;1285-1288.
22. Prins M.H., Turpie A.G. Management of venous thromboembolism. Tooke J.E., Lowe G.D. A Textbook of Vascular Medicine. 1995;515-537 Arnold, London.
23. Greer I.A. Thrombosis in pregnancy: maternal and fetal issues. Lancet. 353:1999;1258-1265.
24. Simmoneau G., Sors H., Charbonnier Bet al. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med. 337:1997;663-669.
25. Bates S.M., Ginsberg J.S. Anticoagulants in pregnancy: fetal effects. Greer I.A. Thromboembolic Disease in Obstetrics and Gynaecology. 11:1997;479-487.
26. Chan W.S., Anand S., Ginsberg J.S. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 160:2000;191-196.
27. Blomback M., Bremme K., Hellgren M., Lindberg H. A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy. Blood Coagul Fibrinolysis. 9:1998;343-350.
28. Casele H.L., Laifer S.A., Woelkers D.A., Venkataramanan R. Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin sodium during pregnancy. Am J Obstet Gynecol. 181:1999;1113-1117.
29. Hainer J.W., Barret J.S., Assaid CAet al. Dosing in heavy weight/ obese patients with the LMWH, tinzaparin: a pharmacodynamic study. Thromb Haemost. 87:2002;817-823.
30. Wilson S.J.A., Wilbur K., Burton E., Anderson D.R. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular-weight heparin for the treatment of venous thromboembolism. Haemostasis. 31:2001;42-48.
31. Sanderink G.J., Liboux A.L., Jariwala Net al. Enoxaparin pharmacokinetics and pharmacodynamics in obese subjects. [abstract] J Am Coll Cardiol. 37(SA):2001;229A. #1076-172.
32. Horlocker T.T., Heit J.A. Low molecular weight heparin: biochemistry, pharmacology, peri-operative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg. 85:1997;874-885.
33. Hull R.D., Delmore T., Carter Cet al. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med. 306:1982;1676-1681.